Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-08-16 Purchase |
2021-08-17 09:11 am |
Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit President & CEO |
6,000 | $1.63 | $9,780 | 95,281 (Direct) |
View |
2021-03-04 Purchase |
2021-03-05 07:05 am |
Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit President & CEO |
1,953 | $2.56 | $5,000 | 89,281 (Direct) |
View |
2021-03-03 Purchase |
2021-03-03 9:05 pm |
Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director |
682 | $3.15 | $2,148 | 13,000 (Direct) |
View |
2021-03-03 Purchase |
2021-03-03 9:00 pm |
Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit President & CEO |
2,500 | $3.03 | $7,575 | 87,328 (Direct) |
View |
2020-08-19 Purchase |
2020-08-19 5:00 pm |
Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit President & CEO |
2,000 | $2.5 | $5,000 | 16,377 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-02-15 Option Award |
2022-02-16 8:10 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Kontulis Caitlin Secretary & VP Finance & Admin |
68,000 | $0 | 107,826 (Direct) |
View |
2022-02-15 Option Award |
2022-02-16 8:08 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Freeman Jonathan E Director |
10,000 | $0 | 20,364 (Direct) |
View |
2022-02-15 Option Award |
2022-02-16 8:06 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director |
10,000 | $0 | 23,000 (Direct) |
View |
2022-02-15 Option Award |
2022-02-16 8:05 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Dorman H. Paul Director |
10,000 | $0 | 20,370 (Direct) |
View |
2022-02-15 Option Award |
2022-02-16 8:03 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit President & CEO |
126,000 | $0 | 221,281 (Direct) |
View |
2022-02-15 Option Award |
2022-02-16 8:01 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | CAUWENBERGH GEERT Director |
10,000 | $0 | 32,822 (Direct) |
View |
2022-02-15 Option Award |
2022-02-16 7:59 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Director |
10,000 | $0 | 25,826 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 9:05 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | CAUWENBERGH GEERT Director |
10,000 | $0 | 22,822 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 9:05 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Dorman H. Paul Director |
10,000 | $0 | 10,370 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 9:05 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Freeman Jonathan E Director |
10,000 | $0 | 10,364 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 9:05 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Lockshin Curtis Director |
10,000 | $0 | 10,366 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 9:05 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Director |
10,000 | $0 | 15,826 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 9:05 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director |
10,000 | $0 | 13,000 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 9:00 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Dispersyn Gerrit President & CEO |
68,450 | $0 | 87,328 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 9:00 pm |
N/A N/A |
Phio Pharmaceuticals Corp. | PHIO | Kontulis Caitlin Secretary & VP Finance & Admin |
34,600 | $0 | 39,826 (Direct) |
View |